Investor AB, an industrial holding company, engaged in owing and developing small and large companies. The company has a diversified portfolio of holdings in the sectors of healthcare, technology, engineering, and financial services. As of December 31, 2002, the company’s portfolio comprised 11 core holdings; approximately 150 new investments; and various other holdings, including its investment in the 3G mobile operator, Hi3G. Holdings Investor's portfolio comprises 11 core holdings, approximately 150 new investments and a number of other holdings. Investor's portfolio is described by sector Healthcare, Technology, Engineering and Financial Services. The company’s core holdings include Ericsson, AstraZeneca, Scania AB, Atlas Copco, WM-data, SEB, Gambro, Electrolux, OM, ABB, and Saab AB. Besides, the company’s new investments business includes private equity investments. Healthcare AstraZeneca: AstraZeneca is a pharmaceutical company focused on research in medicines and pharmaceuticals that is conducted through a global network of research units, mainly in Sweden, the United States and the United Kingdom. Priority research areas are gastrointestinal, cardiovascular, respiratory and central nervous system diseases, as well as pain control and infection. Gambro: Gambro is a global medical technology and healthcare company with positions in renal care and blood component technology. Research and development activities are conducted in Sweden, Germany, Italy, Japan, France and the United States. In 2002, Gambro Renal Products made investments to increase production capacity for synthetic membrane dialyzers. A number of new products were launched on the market, including the Phoenix/Innova hemodialysis machine and the Serena home treatment machine for peritoneal dialysis. Healthcare New investments Affibody Technology, Sweden is a proteomics and biotherapy company leading the development of combinatorial protein engineering to enable high throughput protein characterization in drug discovery and the development of novel biotherapeutics and diagnostic products. Axcan Pharma, Canada, a specialty pharmaceutical company manufacturing and marketing drugs in the area of gastroenterology. Gyros, Sweden has developed miniaturized laboratories in CD format, termed a lab on a chip. Gyro's patented technology represents a breakthrough within the biotechnology sphere. Intuitive Surgical, United States has developed a computer-enhanced, minimally invasive surgery system that combines natural hand movements with techniques used in traditional surgery. ISTA Pharmaceuticals, United States Novel compounds for treatment of serious eye diseases and other maladies. Kyphon, United States develops and markets minimally invasive balloon technologies for the treatment of compression fractures in the spine. Melacure Therapeutics, Sweden discovers and develops novel drugs acting on melanocortin receptors, targeting large unmet medical needs, such as obesity/diabetes, inflammation and sexual dysfunction. Molecular Staging, United States, a life sciences tool company developing technologies for the detection and measurement of proteins and nucleic acids across a broad range of applications in proteomics, genomics and diagnostics. Personal Chemistry, Sweden has developed an automated system for chemical synthesis using a microwave heating technology that speeds up the rate and efficiency of chemical reactions. Songbird Hearing, United States has developed a disposable hearing aid offering the mild-to-moderate hearing-impaired a solution that is convenient and inexpensive. Technology Ericsson: Ericsson supplies telecommunications equipment focusing primarily on mobile telephony. The company continued to develop new mobile phone technologies such as GPRS, EDGE, WCDMA and CDMA 2000. In the first half of the year Investor increased its holding in Ericsson by acquiring 28,000,000 B-shares. Saab: Saab is a high-technology company with activities focused mainly on defense, aviation and space. Operations cover clearly defined areas within defense electronics, missile systems and space electronics, as well a
investor ab-b shs (INVEB:Stockholm)
Stockholm, 103 32
Phone: 46 86 14 20 00
Fax: 46 86 14 21 50www.investorab.com
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for INVEB.|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact INVESTOR AB-B SHS, please visit www.investorab.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.